Treace Medical Concepts Inc
Open
1.92 -4
Overview
Share price change
24h
Min
1.81
Max
2
Income | 6.9M -9.4M |
|---|---|
Sales | 12M 63M |
Profit margin | -15.026 |
Employees | 450 |
EBITDA | 7M -5.2M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +102.99% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | -9.5M 119M |
|---|---|
Previous open | 5.92 |
Previous close | 1.92 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Treace Medical Concepts Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Treace Medical Concepts Inc Forecast
Price Target
By TipRanks
102.99% upside
12 Months Forecast
Average 4.08 USD 102.99%
High 7 USD
Low 2.25 USD
Based on 4 Wall Street analysts offering 12 month price targets forTreace Medical Concepts Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
